| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.4M | +8.6% | +11.4% |
| Cost of Revenue | $3.4M | +4.2% | -0.5% |
| R&D Expense | $5.4M | +12.5% | +14.8% |
| SG&A Expense | $17.5M | +4.6% | -3.7% |
| Operating Income | -$16.3M | -1.8% | +22.5% |
| Pre-tax Income | -$17.4M | +3.0% | +17.5% |
| Income Tax | $40K | +310.5% | +25.0% |
| Net Income | -$17.4M | +2.7% | +17.4% |
| EPS (Basic) | -$1.14 | +1.7% | +5.0% |
| EPS (Diluted) | -$1.14 | +1.7% | +5.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $211.8M | -7.4% | -29.7% |
| Accounts Receivable | $14.3M | +58.9% | +170.6% |
| Current Assets | $233.1M | -8.3% | -27.6% |
| Total Assets | $309.2M | -5.8% | -20.7% |
| Current Liabilities | $53.9M | -11.5% | -2.9% |
| Long-term Debt | $127.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$56.2M | — | — |
| Capital Expenditures | $2.1M | — | — |
| Investing Cash Flow | -$4.7M | — | — |
| Financing Cash Flow | -$8.2M | — | — |
| Free Cash Flow | -$58.3M | — | — |
| +1.5% |
| Total Liabilities | $182.1M | -3.1% | -4.5% |
| Stockholders' Equity | $127.2M | -9.4% | -36.2% |